Previously, Taylor completed a BSc in Psychology at The Queen’s University of Belfast and an MSc in Neuroscience at Trinity College Dublin. Taylor began her doctorate at Imperial College in 2015 after being awarded the MRC Doctoral Training Grant. As a member of the Psychedelic Research Group, she worked within the Centre for Neuropsychopharmacology and the Laboratory for Neuronal Circuit Dynamics to complete two complimentary research projects for her PhD. Following the completion of her PhD, Taylor continued as a Postdoctoral Research Associate collaborating on a variety of psychedelic drug studies here at Imperial and later at the University of California, San Francisco. Taylor continues to contribute to the Centre for Psychedelic Research at Imperial College London as an Honorary Research Associate.
Achievements and Awards
Highest Performing Student 2013
Awarded by The Queen’s University of Belfast for achieving the highest overall grades in the School of Psychology.
Undergraduate Award 2013
Awarded by the British Psychological Society for achieving the highest overall grades in a degree programme accredited by the Society.
Degree Plus Award
Awarded by The Queen’s University of Belfast for acquiring employability skills and experience by participating in extra-curricular activities and work experience.
MRC DTP Studentship Award
Awarded with £105 000 for a 3.5 year training programme, which includes a research project plus training in research methods and transferable key skills, leading to the submission of a doctoral thesis and the award of a PhD. These Medical Research Council Doctoral Training Partnership Studentships are awarded to high calibre researchers who go on to conduct important research and gain worldwide recognition.
et al., 2023, Cortical correlates of psychedelic-induced shaking behavior revealed by voltage imaging, International Journal of Molecular Sciences, Vol:24, ISSN:1422-0067
et al., From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS), Scientific Reports, ISSN:2045-2322
et al., 2022, Body mass index (BMI) does not predict responses to psilocybin, Journal of Clinical Psychopharmacology, Vol:37, ISSN:0271-0749, Pages:107-116
et al., 2022, Validation of the psychological insight scale: a new scale to assess psychological insight following a psychedelic experience, Journal of Psychopharmacology, Vol:36, ISSN:0269-8811, Pages:31-45
et al., 2020, The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner., Journal of Psychopharmacology, Vol:34, ISSN:0269-8811, Pages:786-794
Lyons T, Carhart-Harris RL, 2018, More realistic forecasting of future life events after psilocybin for treatment-resistant depression, Frontiers in Psychology, Vol:9, ISSN:1664-1078
Buchborn T, Lyons T, Knopfel T, 2018, Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice, Frontiers in Pharmacology, Vol:9, ISSN:1663-9812